NCT02496442

Brief Summary

A. Synopsis

  1. 1.This protocol comes to direct the experiment to be performed on the Aqueduct Automatic Continuous Irrigation system.
  2. 2.The Aquaduct System is aimed at reducing risks to the patient by decreasing the irrigation fluid pressure he may be exposed to, reducing the procedure time and therefore the anesthesia time, reducing the manual handling of the sterile bags and the risk of contamination and more.
  3. 3.In general since there is no new procedure suggested and the equipment does not actually come into contact with the human body in any direct way, there is no need to have a clinical study for the regulation purpose. The reason for performing this experiment is to demonstrate the new system and to find out the best way to operate it in order to improve the process and reduce risks.
  4. 4.This information will serve the development of most suitable automation solution for achieving the long desired continuous irrigation.
  5. 5.The experiment will be performed in the OR in MIS procedures, and will replace the standard gravitational manual method of performing the irrigation. The surgeons and the medical staff of the OR will be directed with the set up and operation of the system prior to using it. The experiment will be accompanied at all times with a knowledgeable representative of the research originator.
  6. 6.A maximum of 30 procedures will be analyzed during a period of approximately one month. The surgeons and the medical staff will report their impression of using the system during the procedures and will recommend the best settings achieved.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

July 9, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 14, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

July 14, 2015

Status Verified

July 1, 2015

Enrollment Period

3 months

First QC Date

July 9, 2015

Last Update Submit

July 13, 2015

Conditions

Keywords

Transurethral Resection of ProstateCystoscopyPCNLRERASUrethroscopy

Outcome Measures

Primary Outcomes (2)

  • continuous flow was maintained during the procedure

    evaluation of the continuous nature of the treatment using the Aqueduct

    3 Months

  • Ease of use

    get qualitative assesment of the ease compared to standard procedure

    3 months

Secondary Outcomes (1)

  • ideas for improvements

    3 Months

Study Arms (2)

using Aqueduct

ACTIVE COMPARATOR

Patients passing procedures with Aqueduct

Device: Aqueduct

Not using Aqueduct

NO INTERVENTION

Patients passing the standard procedures

Interventions

AqueductDEVICE

Using Aqueduct in procedures to continuously supply the irrigation solutions

using Aqueduct

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All patients passing the specific procedures set on the Aqueduct

You may not qualify if:

  • Non

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • i.

    BACKGROUND

MeSH Terms

Conditions

Prostatic HyperplasiaKidney CalculiUrinary Bladder Neoplasms

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesNephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrolithiasisUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUrinary Bladder Diseases

Study Officials

  • Boaz Moskovitz, Prof.

    Bnei-Zion

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amir Gilead, MSc

CONTACT

Boaz Moskovitz, Prof. MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2015

First Posted

July 14, 2015

Study Start

July 1, 2015

Primary Completion

October 1, 2015

Study Completion

December 1, 2015

Last Updated

July 14, 2015

Record last verified: 2015-07